EXOGENOUSLY ADMINISTERED INTERLEUKIN-10 DECREASES PULMONARY NEUTROPHIL INFILTRATION IN A TUMOR NECROSIS FACTOR-DEPENDENT MURINE MODEL OF ACUTE VISCERAL ISCHEMIA
Pj. Hess et al., EXOGENOUSLY ADMINISTERED INTERLEUKIN-10 DECREASES PULMONARY NEUTROPHIL INFILTRATION IN A TUMOR NECROSIS FACTOR-DEPENDENT MURINE MODEL OF ACUTE VISCERAL ISCHEMIA, Journal of vascular surgery, 26(1), 1997, pp. 113-118
Introduction: Visceral ischemia and reperfusion associated with thorac
oabdominal aortic aneurysm (TAAA) repair results in lung injury, which
appears to be mediated in part by proinflammatory cytokines. The purp
ose of this study was to determine the effect of exogenous administrat
ion of the antiinflammatory cytokine, recombinant human IL-10 (rhIL-10
), on proinflammatory cytokine production (IL-6 and TNF alpha) and pul
monary neutrophil infiltration after acute visceral ischemia-reperfusi
on. Methods: Two hours before 25 minutes of supraceliac aortic occlusi
on, 80 C57BL/6 mice (20 to 22 g) received an intraperitoneal injection
of rhIL-10 (0.2 mu g [n = 20], 2 mu g [n 20], 5 mu g [n = 25], or 20
mu g [n = 15]), and 16 mice received murine anti-IL-10 IgM 200 mu g. T
wenty-five additional mice underwent visceral ischemia-reperfusion wit
hout treatment (controls), and 16 mice underwent laparotomy without ao
rtic occlusion (sham). Results: Pretreatment with exogenous rhIL-10 re
sulted in significant reductions in lung neutrophil infiltration with
0.2 mu g, 2 mu g, and 5 mu g per mouse of rhIL-10 compared with lung n
eutrophil levels in control mice that underwent acute visceral ischemi
a-reperfusion alone (p < 0.05). In addition, serum TNF alpha was detec
ted in 50% of control mice and in 75% of mice that received murine ant
i-IL-10, but in none of the mice that received rhIL-10 (2 mu g per mou
se) or the mice that underwent sham operative procedures (p < 0.05 by
chi(2) analysis). Conclusion: Exogenous IL-10 limits pulmonary neutrop
hil recruitment and the appearance of TNF alpha in this model of visce
ral ischemia-reperfusion injury. Thus the use of exogenous IL-10 may o
ffer a novel therapeutic approach to decrease the complications that a
re associated with TAAA repair.